Acousia Therapeutics GmbH is a privately held biotech company based in Tübingen, Germany, dedicated to identify small molecules for an innovative treatment of hearing loss.
Location: Germany, Baden-Württemberg, Tübingen
Total raised: $14.54M
Investors 2
| Date | Name | Website |
| - | Esperante | esperante.... |
| - | Creathor V... | creathor.c... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 14.05.2018 | Series B | $11.93M | Creathor V... |
| 16.12.2016 | - | $2.61M | - |
Mentions in press and media 9
| Date | Title | Description |
| 10.01.2024 | Acousia Therapeutics Receives Investment from Esperante Ventures | Acousia Therapeutics GmbH, a Tubingen, Germany-based clinical-stage biotech company developing drug candidates against acute and chronic forms of hearing loss, received an investment from Esperante Ventures. The amount of the deal was not d... |
| 11.05.2022 | Acousia Therapeutics to present its first-in-class hearing loss treatment program with ACOU085 at the 2nd Inner Ear Therapeutics Summit in Boston | Tübingen, Germany, May 11, 2022 Acousia Therapeutics GmbH will be presenting data on the company’s clinical stage, first-in-class lead candidate ACOU085 at the Hanson Wade 2nd Inner Ear Therapeutics Summit to be held in person in Boston (MA... |
| 26.01.2022 | Hearing loss company Acousia Therapeutics to present data for ACOU085 at ARO 2022 MidWinter Meeting February 5–9 | Tübingen, Germany, January 26, 2022 Acousia Therapeutics GmbH – along with its partners from the Translational Hearing Research Group at the Tübingen Hearing Research Center (Department of Otolaryngology, Head and Neck Surgery, University o... |
| 14.05.2018 | Term Sheet — Monday, May 14 | MONDAY MADNESS Good morning, Term Sheet readers. Paid Content What you need to know about growing cyberattacks From ExtraHop NOW, WHAT? Xerox Corp called off its planned $6.1 billion merger with Fujifilm Holdings Corp in a settlement with a... |
| 14.05.2018 | German biotech company Acousia secures €10 million Series B funding to fight hearing loss | Acousia, a Tübingen/Germany-based leader in the discovery and development of novel therapies in inner ear-related diseases and pathologies, has just secured €10 million in a Series B funding round led by Creathor Ventures. Acousia plans to ... |
| 14.05.2018 | Acousia Therapeutics Raises Close to €10M in Series B Funding | Acousia Therapeutics GmbH, a Tübingen, Germany-based leader in the discovery and development of novel therapies in inner ear-related diseases and pathologies, raised close to €10m in Series B funding. Backers included LBBW Ventures, Bregua ... |
| 16.12.2016 | Acousia Therapeutics Closes €2.5M Funding Round | Acousia Therapeutics, a Tübingen, Germany-based biotech company, closed a €2.5m funding round. The round was led by the Boehringer Ingelheim Venture Fund with support from the KfW as well as the new shareholder Axxam SpA of Milan, Italy. In... |
| - | #MakeItTen: Interview with Acousia Therapeutics | Hello, can you hear me? CAN YOU HEAR ME? If not, this is probably because you are reading this. But actually an estimated 10–15 % of us in the developed world suffer from hearing impairment, predominantly caused by the irreversible loss of ... |
| - | Creathor invests in Acousia Therapeutics to fight hearing loss in â¬10 million financing round | Creathor Ventures announced today that it has, together with other investors, invested close to EUR 10 million in a Series B investment round in Acousia Therapeutics GmbH. Acousia is a Tübingen/Germany-based leader in the discovery and deve... |